Viewing Study NCT03409458


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-02-26 @ 4:18 PM
Study NCT ID: NCT03409458
Status: COMPLETED
Last Update Posted: 2023-11-18
First Post: 2018-01-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab
Sponsor: Promontory Therapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer (NSCLC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Solid Tumors View
None NSCLC View
None Non-small cell lung cancer View